ThechiefexecutiveofdrugmakerAstraZenecasaidtheEU's latedecisiontosign a contracttosupplythevaccinemeantthattherewerestillglitchestobesmoothedoutinitsproductionprocess.
It's a muchbetterpicture, butitis a complicatedpicturestill, Sothefirstbigthingthat's happenediswehaveadditionalvaccinecandidatesthathaveshownthemselveswehighlyeffectiveinlatestageclinicaltrials.